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Background: Expression of host microRNAs (miRNAs) changes markedly during influ-
enza A virus (IAV) infection of natural and adaptive hosts, but their role in genetically 
determined host susceptibility to IAV infection has not been explored. We, therefore, 
compared pulmonary miRNA expression during IAV infection in two inbred mouse strains 
with differential susceptibility to IAV infection.
results: miRNA expression profiles were determined in lungs of the more sus-
ceptible strain DBA/2J and the less susceptible strain C57BL/6J within 120 h post 
infection (hpi) with IAV (H1N1) PR8. Even the miRNomes of uninfected lungs differed 
substantially between the two strains. After a period of relative quiescence, major 
miRNome reprogramming was detected in both strains by 48  hpi and increased 
through 120  hpi. Distinct groups of miRNAs regulated by IAV infection could be 
defined: (1) miRNAs (n = 39) whose expression correlated with hemagglutinin (HA) 
mRNA expression and represented the general response to IAV infection indepen-
dent of host genetic background; (2) miRNAs (n = 20) whose expression correlated 
with HA mRNA expression but differed between the two strains; and (3) remarkably, 
miR-147-3p, miR-208b-3p, miR-3096a-5p, miR-3069b-3p, and the miR-467 fam-
ily, whose abundance even in uninfected lungs differentiated nearly perfectly (area 
under the ROC curve > 0.99) between the two strains throughout the time course, 
suggesting a particularly strong association with the differential susceptibility of the 
two mouse strains. Expression of subsets of miRNAs correlated significantly with 
peripheral blood granulocyte and monocyte numbers, particularly in DBA/2J mice; 
miR-223-3p, miR-142-3p, and miR-20b-5p correlated most positively with these 
cell types in both mouse strains. Higher abundance of antiapoptotic (e.g., miR-467 
family) and lower abundance of proapoptotic miRNAs (e.g., miR-34 family) and those 
regulating the PI3K-Akt pathway (e.g., miR-31-5p) were associated with the more 
susceptible DBA/2J strain.
conclusion: Substantial differences in pulmonary miRNA expression between the two 
differentially susceptible mouse strains were evident even before infection, but evolved 
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inTrODUcTiOn
microRNAs (miRNAs) are short regulatory RNA molecules that 
occur in most eukaryotic cells and may have profound effects on a 
broad range of biological processes, including apoptosis, develop-
ment, differentiation, proliferation, and immune responses (1–4). 
It, therefore, comes as no surprise that major changes in miRNA 
expression and activity have been shown to occur as part of the host 
cell response to infection by a variety of viruses (5–7). Increasing 
attention has been paid to the role(s) of miRNAs in influenza virus 
infection, with most studies having focused on influenza A virus 
(IAV). Studies have involved cells or tissues from natural hosts, 
such as humans (8–10), birds (11, 12), pigs (13), and macaques 
(14) and mice as adaptive hosts (15, 16). Major insights have been 
gained by comparing differences in the miRNome responses to 
IAV strains of differential pathogenicity (14–17) or by compar-
ing effects of different host backgrounds (16). The importance 
of some of the differentially expressed miRNAs has also been 
validated experimentally [e.g., Buggele et al. (18)], thus underscor-
ing that miRNAs may substantially influence the course of IAV 
infection (19). However, in spite of this ever growing interest in 
the interactions between IAV and the host miRNome, there have 
been no studies investigating differences in the miRNA response 
in hosts of well characterized differential genetic susceptibility to 
IAV. This is all the more surprising since recent work with inbred 
mouse strains of differential susceptibility to IAV infection clearly 
showed that the transcriptomic (mRNA) response to IAV is to a 
great extent determined genetically (20, 21). It is therefore quite 
plausible that major genetic differences might also manifest at the 
level of the miRNome’s response to IAV infection and that the 
description of this miRNome will enable identification of regula-
tory miRNA–mRNA networks that are critical for successful host 
defense against IAV infection and, perhaps, related viruses. Based 
on a well-established mouse model of IAV infection, and using deep 
sequencing of small RNAs (22), we have therefore used two inbred 
mouse strains of well characterized different genetic susceptibility 
to IAV infection to identify host strain-specific differences in the 
host miRNA response to this virus. We find substantial differences 
in the miRNA populations of the two strains, both at baseline and 
during infection, and an overall more rapid reprogramming in 
the more susceptible DBA/2J strain. The results suggest that host-
strain-specific differences in abundance and regulation of miRNAs 
provide a link to host susceptibility to IAV infection.
MaTerials anD MeThODs
availability of Data
Small RNA sequencing data, a miRNA expression table, and tables 
with expression differences and correlations with hematological 
parameters in peripheral blood, including adjusted p values, are 
available in the Gene Expression Omnibus repository (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89064).
Data tables contain the 473 miRNAs that passed pre-analytic 
filtering. Columns within the table with expression differences 
(GSE89064_edgeR_miR.xls) represent the effect of infection or 
mock treatment compared to untreated mice, differences between 
infection and mock treatment  at each time point, and differences 
between mouse strains after mock treatment, infection, or without 
treatment. All results were obtained with the edgeR package. Data 
table (GSE89064_miRNA_vs_blood_spearman_correlations.
xlsx) contains Spearman correlation coefficients of all miRNAs 
with peripheral blood indices.
statement on ethics approval
All animal work was conducted according to the national 
guidelines of the animal welfare law of the Federal Republic of 
Germany and approved by the “Niedersächsisches Landesamt 
für Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, 
Germany” (Permit Numbers: 3392 42502-04-13/1234 and 33.19- 
42502-04-13/1234).
Virus
Original stocks of mouse adapted A/Puerto Rico/8/34 (H1N1, 
PR8) virus were obtained from Stefan Ludwig (University of 
Münster) (23). Virus stocks were propagated in the chorioal-
lantoic cavity of 10-day-old pathogen-free embryonated chicken 
eggs for 48 h at 37°C as described previously (24).
animal Procedures
Infections were essentially carried out as described previously 
(20, 25). Briefly, female 12- to 13-week-old C57BL/6J and DBA/2J 
mice (n = 5–6 per time point and treatment) were anesthetized 
by intraperitoneal injection of 10  μl/g body weight of a stock 
solution of 0.5  ml ketamine (50  mg/ml, Invesa Arzneimittel 
GmbH, Freiburg, Germany), 0.5 ml 2% xylazine hydrochloride 
(Bayer Health-Care, Leverkusen, Germany), and 9  ml sterile 
NaCl 0.9% (Delta-Select GmbH, Dreieich, Germany). For 
intranasal infection, a viral dose of 2 × 103 focus forming units 
(ffu) in a total volume of 20 μl sterile PBS was used. During the 
infection procedure, mice were held in the upright position and 
additional anesthetic was reinjected as needed. Mock treatment 
was identical to the real anesthesia/infections except that vehicle 
only (sterile PBS), not containing virus, was used for intranasal 
instillation. Mice were weighed on day 0 just before induction 
of anesthesia and on each subsequent day. Mice were killed by 
CO2 asphyxiation at 6, 12, 18, 24, 48, and 120 h with respect to 
infection or mock treatment. Untreated mice were used as t = 0 h 
control. Lungs were removed by cutting the five main bronchi 
further throughout infection and could in part be attributed to differences in peripheral 
blood leukocyte populations. Thus, pulmonary miRNA expression both before and 
during IAV infection is in part determined genetically and contributes to susceptibility to 
IAV infection in this murine host, and likely in humans.
Keywords: biomarkers, genetics, infection, influenza virus, lung, mirna, mouse, susceptibility
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and were washed in RNAlater RNA Stabilization Reagent (Qiagen 
Inc., Venlo, Netherlands), immediately after removal. After trans-
fer into a new tube containing 2 ml RNAlater, lungs were stored 
overnight at 4°C and then at −20°C until further use.
hematological Measurements
An analysis of the hematological data from this time course 
experiment has been published separately (25). Briefly, 50  μl 
of whole blood were obtained by cardiac puncture and then 
analyzed with a VetScan HM5™ (Abaxis, Union City, CA, USA) 
hematology analyzer.
rna isolation
Lungs were homogenized in 4 ml RLT buffer (Qiagen) containing 
40 μl β-mercaptoethanol and stored in 450 μl aliquots at −80°C. 
After thawing, 450 μl of this suspension was mixed with 700 μl 
Qiazol (Qiagen), and all further steps of total RNA isolation were 
performed with the miRNeasy kit (Qiagen) according to the 
manufacturer’s recommendations.
small rna sequencing
Five samples per condition were submitted for small RNA sequenc-
ing. Sequencing was performed using the TruSeq™ Small RNA 
Sequencing Kit, Version of January 2011 (Illumina, Inc., San Diego, 
CA, USA). Approximately 1,250 ng of input RNA was used and 
the synthesized cDNA was amplified with 15 PCR cycles. cDNA 
library fragments with a length of about 150  nt were separated 
by gel electrophoresis and then isolated from the corresponding 
excised gel slice. Four to five biological replicates per condition were 
analyzed. Use of the Illumina molecular barcode allowed sequenc-
ing of eight samples per lane. To reduce batch effects, samples from 
the same time point and mouse strain were never run on the same 
lane. Sequencing was done using the HiSeq 2500 (Illumina Inc.) 
sequencer. The TruSeq™ Small RNA Sequencing Kit is specific for 
miRNAs and other small RNAs that have a 3′OH group resulting 
from enzymatic cleavage by RNA processing enzymes.
Quantitative real-time Pcr (rT-qPcr)
Quantitative real-time PCR was performed with a LightCycler 
480® (La Roche AG, Basel, Switzerland) in 96-well plates in 20 μl 
reaction volumes, using 3  ng cDNA per reaction for miRNAs 
(miScript Reverse Transcription Kit, miScript SYBR Green 
PCR Kit; Qiagen) or 15 ng cDNA per reaction for detection of 
IAV hemagglutinin (HA) mRNA. Aliquots from the same RNA 
samples as for the sequencing experiment were used, with five 
biological replicates for each condition. HA expression was 
normalized against the mean of the Ct values of Actb and Rpl4 
mRNAs. Ct values of the miRNAs were not normalized against 
an internal control.
Data analysis
Illumina sequencing data were preprocessed using the CLC 
Genomics Workbench 6.04 (CLC Bio, Cambridge, MA, USA) 
and the resulting sequences were annotated using miRBase 19. 
Two additional downstream and upstream bases as well as two 
mismatches were allowed. 5′ and 3′ mature sequences (including 
variants) were used for further analysis. All subsequent analyses 
were done using the R environment and programming code (26). 
All p values were adjusted for false discovery rate (FDR).
Two samples were excluded before sequencing due to poor 
RNA quality/quantity, and three samples were excluded after 
sequencing due to low read numbers. Thus, small RNA sequenc-
ing data of 125 of the 130 originally submitted samples (96%) 
were available for analysis, amounting to five biological replicates 
for most conditions, but only four for the following conditions: 
untreated (0 h), mock treated (6 h), and infected (18 hpi) DBA/2J 
mice, and mock treated (6 and 120 h) C57BL/6J mice. A total of 
1,276 miRNAs were detected. Only the 476 annotated sequences 
that were detected at a level of >1 count per million (CPM) in 
>5 samples were included in subsequent analyses. This did not 
change the number of total reads appreciably. Three miRNAs with 
strong outlier samples were removed because of an SD/median 
ratio >2.5 (calculated with cpm values of mouse strain and time 
post treatment). Line plots of these miRNAs did not show any 
relevant change in expression (data not shown).
Differentially expressed miRNAs were identified using 
 generalized linear models contained in the edgeR package (27). 
For expression changes within a time course or differences 
between mock treated and infected mice, a fold change (FC) of 
1.5 and p value of 0.05 were used as cutoff.
Differential miRNA expression in response to IAV infection 
was defined as follows: (1) significant (p ≤  0.05) with respect 
to the untreated control (t = 0 h) and to the mock-treated mice 
at the same time point and (2) a ≥1.5 FC difference from the 
untreated mice. miRNAs that were differentially expressed due 
to the infection procedure, excluding the virus, were defined as 
follows: significant regulation after mock treatment and infection 
with respect to t = 0 h, but no significant expression difference 
between infected and mock samples from the same time point 
(p ≥  0.05). A FC cutoff of ≥1.5 between untreated and mock-
treated mice was used.
To compare absolute miRNA abundance in DBA/2J vs 
C57BL/6J mice, we used miRNAs that were differentially 
expressed in response to infection in at least one mouse strain 
and differed between the mouse strains, using the more rigorous 
FC cutoff of 2 and p ≤ 0.01. Furthermore, we defined a miRNA 
subset with no significantly different abundance between both 
mouse strains at all tested time points (ratio ≤ 1.5; p ≥ 0.1), but 
differential expression after IAV infection in either mouse strain. 
Clusters using k-means for longitudinal data were calculated 
using the kml package (28). Graphs were made using lattice (29), 
gplots (30), or ggplot2 (31).
Functional Prediction
microRNAs that were found to differ between the two mouse 
strains were analyzed using three different approaches. From 
the significantly enriched pathways, we removed those that 
did not differ from putative pathways of miRNAs with similar 
abundance in both mouse strains. For the first approach, we used 
the DIANA mirPath v2 online tool (32) for annotated miRNA 
contained in miRBase 18. As settings, we used microT-CDS for 
target prediction with a threshold of 0.8. Results were visualized 
with a p value threshold of 0.05 using the option “pathways 
union.” This option shows the contribution of each miRNA to 
FigUre 1 | Weight loss and expression of influenza a virus (iaV) 
hemagglutinin (ha) mrna. Weight loss and HA mRNA expression 
throughout the 5-day time course after mock treatment or infection with IAV 
strain PR8 as outlined in Section “Materials and Methods.” (a) Weight loss, 
expressed as the mean percentage of body weight measured at t = 0 h 
before administration of anesthesia. No mice had to be killed because of 
>30% weight loss. Data are based on the mice that were sacrificed at the 
120 h time point (n = 5–6 per group). (B) Relative quantification of IAV HA 
mRNA in mouse lung by RT-qPCR in the 5-day time course shown in panel 
A. dCt refers to Ctreference − Cttarget mRNA, where Ctreference is the arithmetic mean 
of the Ct values of β-actin and Rpl4. As expected, HA mRNA was not 
detected in the mock-treated mice (data not shown). Data are based on five 
mice per group except for DBA/2J at 18 h (n = 4). Solid lines, infection; 
interrupted lines, mock treatment. Left panels, DBA/2J strain; right panels, 
C57BL/6J strain. The colored areas around the lines indicate SD. Note that 
the x-axes of the panels are based on different scales. *p ≤ 0.05 for 
difference with respect to t = 0 h; ‡p ≤ 0.05 for difference between 
mock-treated and infected mice at the given time point (Tukey’s test). This 
figure is adapted from two articles published by BioMed Central (21, 25), 
which describe other aspects of this time course experiment.
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the pathways enrichment, showing only miRNAs whose targets 
are significantly (p ≤ 0.05) enriched for that pathway. From the 
significant pathways, we removed those with a 1.5-fold lower 
number of significant miRNAs for the same pathway in the 
control group of miRNAs with similar abundance between the 
two mouse strains.
For the second strategy, we used putative miRNA targets that 
were found in at least three of four databases (MicroCosm, PITA, 
miRanda and miRDB) [MicroCosm (33); miRanda (34); miRDB 
(35); PITA (36)]. Targets that were shared by at least two miRNAs 
were chosen for functional analysis.
Using the R packages “goseq” and “GO.db,” we identified 
significantly enriched GO Terms using putative targets of all 473 
detected miRNAs as background. Of the significantly enriched 
terms for host strain-dependent miRNAs, we chose only those 
which had at least 1.5-fold more targets for a pathway, compared 
to the control group with similar miRNA abundance, or that were 
not found in the control group.
Putative miRNA targets of step 2 were analyzed using the 
online tool DAVID (Database for Annotation, Visualization 
and Integrated Discovery) Bioinformatics Resources 6.7 (37, 38) 
and the Mus musculus genome as background. For functional 
observations, we used default settings. Results of the DAVID tool 
included a Functional Annotation Table with functional terms 
for each gene; a Functional Annotation Chart that calculates 
the enrichment of each term and a Functional Annotation 
Clustering that clusters Terms that are related. Of the Functional 
Annotation Table, we added the options fold enrichment and 
FDR. Functional Annotation Charts were downloaded and 
loaded into the R program to allow direct comparisons of dif-
ferent enrichment tables. To identify functions of miRNAs with 
different abundance in DBA/2J and C57BL/6J mice, only those 
significantly enriched terms (FDR  ≤  0.05) were chosen that 
were found for miRNAs with different, but not for miRNAs with 
similar abundance in both mouse strains or were at least 1.5-fold 
more highly enriched.
Other statistical analyses
For pairwise comparisons of miRNA or mRNA Ct values, we used 
Tukey’s Honest Significant Differences Test for homogeneous 
variances. We used a significance threshold of p ≤ 0.05. Receiver 
operating characteristic (ROC) curve analysis was performed 
using the R package ROCR (39) and counts per million (cpm) 
data.
resUlTs
Brisker Progression of infection and More 
Pronounced Weight loss in the DBa/2J 
Mouse strain
Higher weight loss, compared to less susceptible mouse 
strains, is a hallmark of the high susceptibility of DBA/2J mice 
to IAV infection. Consistent with our previous observations 
(40), marked weight loss was observed after infection of this 
strain, which reached a maximum of approximately 25% by 
day 5 (Figure 1A). As shown previously (40), weight loss of 
the less susceptible strain, C57BL/6J, was less pronounced, as 
reflected in a mere 5–10% reduction by day 4–5. There was no 
significant weight loss among the mock-treated mice between 
day 1 and 5.
Quantitative real-time PCR revealed a brisk rise of mRNA 
encoding IAV HA in lungs of both mouse strains after infection 
(Figure 1B). HA mRNA was detected at low levels as early as 
6  hpi in both strains, followed by a rapid rise that peaked at 
48 and 120  hpi in DBA/2J and C57BL/6J mice, respectively. 
HA mRNA levels were significantly higher in DBA/2J than 
FigUre 2 | global mirna expression changes throughout the 120 h time course of influenza a virus infection. Values of all 473 miRNAs that passed 
preanalytical filtering are shown in panels (a,B) (turquoise lines, mock treatment; red lines, infection). (a,B) change in expression (log2); FC was calculated with the R 
package edgeR (27). (a) DBA/2J strain; (B) C57BL/6J strain. (c) Multidimensional scaling based on the expression data of all 473 detected miRNAs (edgeR 
package). The data, as well as the data shown in Figures 3–6, are based on five mice per condition, except that four mice were available for untreated (0 h), mock 
treated (6 h), and infected (18 h) DBA/2J mice, and for mock treated (6 and 120 h) C57BL/6J mice.
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in C57BL/6J. This difference was significant as early as 12 hpi 
with a ratio DBA/2J to C57BL/6J of 3.6:1 and increased to a 
constant ratio of about 23 to 24:1 between 18 and 48  hpi, 
which diminished markedly by 120  hpi due to a decline in 
HA transcript levels in the DBA/2J strain by this time point. 
Thus, the infection evolved more briskly and peaked sooner in 
the more susceptible DBA/2J strain, with differences manifest-
ing as early as 12 hpi.
global changes in mirna expression 
throughout the Time course
Eighty-eight percent (10.7 million on average) of all obtained 
sequences corresponded to annotated miRNAs. A total of 
473 miRNA species passed pre-analytic data processing and 
were selected for subsequent analyses. In both mouse strains, 
analysis of the 473 selected miRNAs (Figures 2A,B) revealed a 
FigUre 3 | Potential contributions of infiltrating leukocytes to pulmonary mirnome reprogramming. (a) Line plots visualizing the associations between 
miRNA abundance and direction of regulation of miRNAs regulated in response to influenza A virus (IAV) infection (115 different miRNA species, FC ≥|1.5|, FDR 
adjusted p value ≤ 0.05 in either mouse strain, see Figure 4). The clusters were identified with the k means of longitudinal data (kml) package of R (28) using the FC 
(log2) data of IAV infected mice compared to untreated (t = 0 h) mice. (B) Correlation of miRNA expression with peripheral blood leukocyte parameters. Using data 
from infected and control (uninfected) mice, expression (cpm) of 473 miRNAs was correlated with hematological parameters of the same mice. Significant 
correlations (Spearman correlation; ρ ≥|0.5| and p ≤ 0.05) are indicated in different colors according to mouse strain: red, significant correlation in DBA/2J only; blue, 
significant correlation in C57BL/6J only; violet, significant correlation in both strains. The green smoothing line was generated using the R function smooth.spline 
(stats package) using default settings. WBC, white blood cells; LYM, LYM%, absolute and relative lymphocyte counts; MON, MON%, absolute and relative 
monocyte counts; GRA, GRA%, absolute and relative granulocyte counts.
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narrow range in miRNA expression FC during the time course. 
Accordingly, multidimensional scaling (MDS, Figure  2C) 
revealed that samples from mock-treated and infected mice at 
any time point between 6 and 24 h formed two tight clusters (one 
for each mouse strain) with the respective uninfected (t = 0 h) 
mice. In the DBA/2J mice, an apparent weak up and downregula-
tion of some miRNAs due to the mock treatment was seen at 6 h 
(Figures 2A,B), but this was not statistically significant, and there 
was no apparent tendency toward a mock effect in the C57BL/6J 
strain. Thus, the infection/anesthesia procedure did not induce 
significant changes in miRNA populations in either mouse strain. 
Of note, a marked difference in miRNomes between the strains 
was apparent even in the uninfected lungs (Figure  2C). These 
strain-specific differences dominated the global differences in 
miRNomes throughout the time course, which remained rela-
tively constant.
In both mouse lines, line plots (Figures  2A,B), MDS 
(Figure  2C), and Euclidian distance dissimilarity analysis 
(EDDA, data not shown) consistently indicated a global miRNA 
reprogramming beginning at 48 hpi, followed by a pronounced 
further increase at 120 hpi. The overall mean FC was constant 
within the first 24  h and increased in DBA/2J and C57BL/6J 
mice after 48 h and 120 h, respectively. As indicated by MDS and 
confirmed using EDDA, miRNome reprogramming at 48  hpi 
was greater in the DBA/2J than the C57BL/6J strain, whereas the 
two strains reached a similar overall degree of reprogramming 
by 120  hpi. Notably, HA mRNA expression in DBA/2J mice 
decreased between 48 and 120 hpi (Figure 1B), but miRNome 
reprogramming increased further during the same time frame. 
Therefore, host miRNA reprogramming did not seem to be 
coupled directly to viral HA RNA expression.
To test whether there was any association between the initial 
expression level of the infection-regulated miRNAs and the direc-
tion of their regulation, the 115 infection-regulated miRNAs (dif-
ferentially expressed in DBA/2J or C57BL/6J mice with respect 
to mock-infected mice; FC ≥|1.5|, FDR adjusted p value ≤ 0.05) 
were grouped into three clusters according to baseline expres-
sion level and direction of regulation (Figure  3A). Indeed, a 
negative correlation between initial expression and direction of 
regulation was identified in both mouse strains: downregulated 
miRNAs tended to have a high baseline expression level, interme-
diately upregulated miRNAs an intermediate baseline expression 
level, and strongly upregulated miRNAs the lowest. The three 
clusters converged toward 120 hpi, at a point corresponding to 
approximately five normalized and log2 transformed reads (log2 
counts per million; cpm). Thus, the direction of regulation of the 
miRNAs depended on their initial abundance (expression level). 
These observations are consistent with a model in which miR-
NAs with high baseline expression are predominantly expressed 
in resident lung cells, but miRNAs of low initial abundance are 
mainly expressed in immune cells and their abundance increases 
during infection due to their immigration into the lung combined 
with the corresponding changes in their activation state.
To assess the contributions of changes in immune cell popula-
tions to changes in miRNA expression, we quantified correlations 
between peripheral blood leukocyte parameters and expression 
of each of the miRNAs (Figure 3B). Overall, higher numbers of 
significant correlations were measured in DBA/2J mice [compare 
red (DBA/2J) and and blue (C57BL/6J) circles in Figure 3], which 
was particularly pronounced in total leukocyte (WBC) and 
monocyte counts. Absolute granulocyte numbers and miRNA 
expression correlated most significantly in both mouse strains (23 
miRNAs with significant correlations; violet circles in Figure 3), 
with miR-223-3p, miR-142-3p, and miR-20b-5p correlating the 
most positively in both mouse strains ([ρDBA/2J + ρC57BL/6J]/2 > 0.7). 
There was only a negligible correlation (one miRNA in DBA/2J 
mice) with absolute lymphocyte counts. To test the above stated 
hypothesis that pulmonary miRNAs expressed in infiltrating 
immune cells are initially expressed at low level in the lung, we 
asked whether there was an association between miRNA correla-
tion with peripheral blood indices and initial miRNA abundance. 
Indeed, miRNAs that correlate positively (ρ ≥ 0.2) with MON, 
GRA, GRA/LYM, and GRA% had a lower initial abundance 
(≥1.5-fold lower; p value ≤ 0.01, Wilcoxon test) than miRNAs 
that correlate negatively (ρ ≤ −0.2). Taken together, these results 
suggest that expression of pulmonary miRNAs during the first 
120 h of infection may be in part explained by infiltration with 
myeloid immune cells, particularly in the more susceptible 
DBA/2J strain.
Mouse strain-specific Differences in 
mirnome regulation after iaV infection
As mentioned above, 115 miRNAs were significantly regulated 
after infection. The majority (75%) were upregulated and 
only about 25% were downregulated. Of note, the number of 
differentially expressed miRNAs and their FC direction was 
similar in both mouse strains (Figure 4), i.e., miRNAs that were 
upregulated in one strain, were also upregulated in the other, 
and vice versa. In both strains, a first significant response to the 
infection was apparent at 48 hpi, with a slightly higher number 
of differentially expressed miRNAs and higher FC values being 
observed in the DBA/2J strain than in the C57BL/6J strain. An 
at least twofold greater induction in C57BL6/J mice was detected 
in eight miRNAs (miR-190a-3p, miR-449a-5p, miR-449a-3p, 
miR-449c-5p, miR-3096a-5p, miR-3096b-5p, miR-3096b-3p, 
and miR-669c-5p). Consistent with MDS and EDDA, the two 
strains reached a similar overall degree of reprogramming by 
120 hpi, but differences at the earlier time points were greatest 
at 48 h.
In a next step, we tried to identify miRNAs that might con-
tribute to the differences in miRNomes between the two mouse 
strains revealed in Figure  2 and, thus, might affect host strain 
susceptibility. Abundances of a subset of 37 infection-regulated 
miRNAs differed (FC ≥|2|, FDR adjusted p value  ≤  0.01) 
between the two mouse strains at any of the tested time-points 
(Figure  5), 22 of which were more abundant in DBA/2J and 
15 more abundant in C57BL/6J mice. Six of these (16%) were 
significantly infection-regulated in DBA/2J only and 10 (27%) 
in C57BL/6J only. Pulmonary expression of eight miRNAs 
differed between the two mouse strains even before infection. 
Expression of 10 miRNAs differed significantly between the 
two strains between 6 and 18 hpi, expression of 13 miRNAs at 
24 hpi, expression of 20 miRNAs at 48 hpi, and expression of 23 
FigUre 4 | mirnas regulated during influenza a virus (iaV) infection. Heat map showing all 115 miRNAs that were differentially expressed after IAV infection 
(see Materials and Methods) of DBA/2J and/or C57BL/6J mice. FC data and p values (FDR adjusted) represent the difference between infected and mock-treated 
mice. Red: upregulated; blue: downregulated. The right bar indicates log2 counts per million (edgeR package) of these miRNAs in DBA/2J and C57BL/6J mice 
together, ranging from low (white) and mid (blue) to high (black) abundance. Expression of 93 miRNAs changed during the infection in the DBA/2J strain and 95 in 
the C57BL/6J strain, corresponding to a total of 115 regulated miRNAs. Seventy-three of these were regulated in both strains (***p value ≤ 0.001; **p value ≤ 0.01; 
*p value ≤ 0.05). Stars are only shown for differences between infected and mock-treated mice and were also included for significant miRNAs with an FC <|1.5|.
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FigUre 5 | mirnas that differ in absolute abundance between DBa/2J and c57Bl/6J mice. Depiction of 37 miRNAs with a differential abundance of ≥|2| 
and a p value (FDR adjusted) of at ≤0.01 between DBA/2J and C57BL/6J mice throughout the time course. Red colors in the heat map indicate miRNAs that are 
more abundant in DBA/2J mice (22 miRNAs), blue colors indicate miRNAs that are more abundant in C57BL/6J mice (15 miRNAs). The 115 miRNAs that are 
infection dependently regulated in DBA/2J or C57BL/6J mice (Figure 4) were used as input miRNAs. The blue bar indicates mean miRNA abundance across all 
samples (log2 cpm). The FC of these miRNAs at 120 hpi is shown using shades of blue (low DBA/2J vs C57BL/6J ratio, i.e., higher abundance in C57BL/6J mice) 
and shades of red (high DBA/2J vs C57BL/6J ratio, i.e., higher abundance in DBA/2J mice) (***p value ≤ 0.001; **p value ≤ 0.01; *p value ≤ 0.05). Stars were also 
included for significant miRNAs with an absolute ratio <2.
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miRNAs at 120 hpi. The miRNAs whose expression was lower/
higher in DBA/2J mice in the uninfected state mainly continued 
to be expressed at a lower/higher level after infection, even after 
5 days. Thus, two major patterns could be discerned among the 
host strain-dependently regulated miRNAs: (1) miRNAs that 
were differentially expressed in the two strains throughout the 
entire time course, and (2) miRNAs whose differential expression 
manifested at the later time points. Most miRNAs of group two 
were more abundant in DBA/2J mice. miR-147-3p constituted 
an exception in that it was markedly overexpressed in C57BL/6J 
mice within the first 24  hpi and had a similar expression level 
as DBA/2J at 48 hpi. miR-3096b-3p and miR-3096b-5p showed 
the strongest host strain-dependent difference in both directions. 
The DNA Intelligent Analysis (DIANA), the Gene Ontology ana-
lyzer for RNA-seq data (R package goseq), and the Database for 
Annotation, Visualization, and Integrated Discovery (DAVID) 
were then used to search for putative mRNA targets of miRNAs 
whose expression was different between the two mouse strains 
(Figure  5) and the functional pathways putatively associated 
with these mRNAs. Among the pathways relating to immune 
functions, Fc gamma R-mediated phagocytosis, HIF-1 signaling 
pathway, positive regulation of protein kinase B signaling cascade, 
FigUre 6 | apoptosis-related mirnas that differ in absolute 
abundance between DBa/2J and c57Bl/6J mice. Data are based on 
those shown in Figure 5. Red, higher expression in DBA/2J mice; blue, 
higher expression in C57BL/6J mice. Functional information was found by 
literature research as described in the text above.
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SH3 binding, and leukocyte differentiation were significantly 
over-represented.
There were also distinctive features within each of the two 
major miRNA expression patterns mentioned above. For 
instance, miRNAs whose abundance did not differ between 
uninfected and incipiently infected mice tended to be more 
highly expressed in DBA/2J mice at 48 hpi. Furthermore, seven 
miRNAs were expressed more highly in C57BL/6J mice and 
were mainly downregulated across the time course (miR-92b-3p, 
miR-34b-5p, miR-672-5p, miR-31-5p, miR-34c-5p, miR-34b-3p, 
and miR-182-5p; listed in descending order according to the heat 
map in Figure 5). Although these miRNAs were less abundant 
in DBA/2J mice, they were downregulated even more strongly 
in this strain. In addition, the absolute abundance of these 
miRNAs was relatively high, suggesting that they are expressed 
in resident lung cells and not in infiltrating immune cells. Indeed, 
in DBA/2J all seven miRNAs (and four of seven in C57BL/6J) 
belong to the upper trajectory cluster in Figure  3. By using 
functional enrichment of putative targets, PI3K-Akt signaling 
pathway, Notch signaling pathway, hemopoiesis, leukocyte dif-
ferentiation, natural killer cell mediated cytotoxicity, and different 
cancers were among the enriched functions. When considering 
all 37 infection-regulated miRNAs whose expression differed 
between the two mouse strains, nine miRNAs had targets that 
were significantly over-represented in the PI3K-Akt signaling 
pathway (DIANA tool). Five of these [miR-34b-3p, miR-34c-5p, 
miR-34b-5p, miR-92b-3p, and miR-182-5p; as well as miR-31-5p, 
which was identified through literature search (41)] belonged to 
the aforementioned seven miRNAs which were expressed more 
highly in the C57BL/6J mice and downregulated throughout the 
time course.
mirnas That are More abundant in the 
c57Bl/6J strain contain More Putative 
Binding sites for iaV rna
To test whether these 37 miRNAs (Figure 5) might contribute 
to the higher IAV resistance of C57BL/6J mice, we searched 
for putative binding sites for them in the IAV genome. Using 
the ViTa Database, the human homologs of miR-135b-5p, 
miR-147-3p, miR-31-5p, miR-379-5p, miR-7a-5p, as well as the 
miR-449 (-5p) and miR-34 (-5p) families, were predicted to bind 
to viral RNA segments of influenza A/Puerto Rico/8/34/Mount 
Sinai (H1N1). Most of these miRNAs were more abundant in 
C57BL/6J mice (p =  0.013, hypergeometric test) and might, 
therefore, contribute to the higher resistance of C57BL/6J mice 
to IAV infection.
Potential involvement of apoptotic 
Processes in host-strain susceptibility 
to iaV infections
Many miRNAs whose expression differed between DBA/2J and 
C57BL/6J mice during infection belong to the miR-467, miR-449, 
and miR-34 families. Of note, all three families have been shown 
to play roles in apoptosis (42–44), and several publications have 
demonstrated the relevance of apoptosis to IAV infection (17, 
45–47). We therefore tested whether there might be an association 
between strain-specific miRNA expression and apoptosis. As 
shown in Figure  6, miRNAs that were more highly expressed 
in the susceptible DBA/2J strain tended to be antiapoptotic, 
whereas miRNAs that were more highly expressed in the resistant 
C57BL/6J strain tended to be pro-apoptotic (p = 0.002, two-tailed 
Fisher exact test) (42–44, 48–53).
iaV-regulated mirnas with host-strain-
specific expression in the absence of 
infection
Considering the differences between the pulmonary miRNomes 
of the two mouse strains even before IAV infection (Figure 2C), 
we used receiver operating characteristic (ROC) curve analysis 
to identify miRNAs whose expression levels differed consist-
ently between the two mouse strains in the absence of IAV 
infection and which might, therefore, be used in the uninfected 
state to predict intrinsic host susceptibility. To increase the sam-
ple size and, therefore, statistical power, this analysis comprised 
all treatments and time points that did not show evidence of 
infection-dependent miRNA expression changes, i.e., untreated 
mice (0  h), mock-treated mice (6–120  h), and infected mice 
in the first 24  hpi (6–24  h). This amounted to a sample size 
of 52 DBA/2J mice and 53 C57BL/6J mice. Five miRNAs were 
identified with areas under the ROC curve (AUC) = 1, indicat-
ing that there was no overlap in their expression levels between 
the two strains, and expression of four of them changed during 
infection (Figure  7). In total, there were eight differentially 
FigUre 7 | mirnas with consistently different expression in DBa/2J and c57Bl/6J mice. miRNAs that have an AUC = 1 for the separation between 
uninfected, mock treated, and incipiently infected (6–24 h) DBA/2J from C57BL/6J mice. Data are based on 52 DBA/2J mice (4 at 0 h, 10 at 12 h, 9 at 18 h, 10 at 
24 h, and 5 at 48 and 120 h) and 53 C57BL/2J mice (5 at 0 h, 10 at 12, 18 and 24 h, 5 at 48 h, and 4 at 120 h). Dots indicate the normalized (cpm) miRNA 
expression in DBA/2J (red) and C57BL/6J (blue) mice. All shown miRNAs are differentially expressed in at least one mouse strain after influenza A virus infection 
(Figure 4).
FigUre 8 | Validation of mirna expression using quantitative real-time Pcr (rT-qPcr). RT-qPCR validation experiment for five selected miRNAs (compare 
Figures 4 and 5). The same mouse lungs were used as for the sequencing experiment. Colors indicate (a) mean log2 fold change expression with respect to the 
untreated control or (B) miRNA expression differences between the DBA/2J and the C57BL/6J mouse strain. Red: (a) upregulated miRNA, (B) higher expression in 
DBA/2J mice; blue: (a) downregulated miRNA, (B) higher expression in C57BL/6J mice (***p value ≤ 0.001; **p value ≤ 0.01; *p value ≤ 0.05). All p values were 
false discovery rate adjusted.
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expressed miRNAs with AUCs  >  0.99 (miR-147-3p, miR-
208b-3p, miR-467a-5p, miR-467c-5p, miR-467d-5p, miR-
467e-5p, miR-3096a-5p, and miR-3096b-3p) whose abundance 
changed significantly during infection. Most of these highly 
strain-specifically expressed miRNAs (except miR-147-3p and 
miR-3069a-5p) were expressed more highly in the DBA/2J 
strain. Overall, miRNAs belonging to the miR-467 family were 
over-represented in this group of strain-specific miRNAs: 11 
miRNAs of this family were among the 473 miRNAs that passed 
initial data filtering (see Materials and Methods), and nine of 
them had AUCs > 0.946. Taken together, the above results sug-
gest (1) that the selective expression of several IAV-regulated 
miRNAs, including miR-147-3p, miR-208b-3p, miR-3096a-5p, 
miR-3069b-3p, and the miR-467 family, in uninfected and 
incipiently infected DBA/2J lungs was specifically associated 
with higher susceptibility of this mouse strain to IAV infection 
at later time points and (2) that it accurately predicted this 
higher susceptibility.
Technical Validation of rnaseq results 
with rT-qPcr
Five miRNAs were chosen that exemplify three patterns of 
expression differences between DBA/2J and C57BL/6J mice. 
These are comprised of miRNAs with a lower (miR-34b-5p and 
miR-92b-3p) or higher (miR-467e-5p) expression in DBA/2J 
vs C57BL/6J mice throughout the time course and those that 
are more highly expressed at 48 or 120  hpi only (miR-223-3p 
and miR-21a-3p). RNA from the same mice was used for both 
analyses. When expressing the RNAseq data as CPM, RT-qPCR 
data of four of the five miRNAs correlated strongly with the 
RNAseq data (ρ =  0.8 each, p ≤  0.05, Spearman correlation), 
whereas miR-92b-3p did not correlate significantly (ρ =  0.25, 
p = ≥  0.05). When FC values were used, RT-qPCR detected 
changes in miR-21a-3p, miR-223-3p, and miR-34b-5p expres-
sion in the same direction as measured by RNAseq, whereas 
no significant regulation was observed for miR-467e-5p and 
miR-92b-3p (Figure 8A). The RT-qPCR analysis confirmed the 
higher expression of miR-223-3p, miR-21a-3p, and miR-467e-5p 
in DBA/2J and the lower expression of miR-34b-5p and miR-
92b-3p after infection, compared to C57BL/6J (Figure 8B). The 
RT-qPCR data differed in a minor way from the RNAseq data 
in that expression of miR-34b-5p and miR-92b-3p at t = 0 did 
not differ significantly between the mouse strains (Figure 8B). 
Taken together, these results suggest that there is substantial, 
but not perfect, agreement between the RT-qPCR and RNAseq 
data, thus validating our approach to use RNAseq for miRNA 
profiling.
FigUre 9 | correlation of mirna expression with hemagglutinin (ha) mrna expression. Correlation of miRNA expression with HA mRNA expression using 
small RNA sequencing data of the 473 detected miRNAs (see Materials and Methods) and relative expression of HA mRNA obtained with quantitative real-time PCR 
(RT-qPCR). For the correlation analysis, cpm values of infected mice minus cpm values of mock-treated control mice were used. (a) Correlation of 473 miRNAs with 
HA mRNA expression in DBA/2J (x-axis) and C57BL/6J (y-axis) mice. Colors indicate 105 miRNAs that significantly correlated in at least one of the mouse strains. 
Red dots, miRNAs that correlate in DBA/2J only (ρ ≥ |0.5|, FDR ≤ 0.05); blue dots, miRNAs that correlate in C57BL/6J only (ρ ≥ |0.5|, FDR ≤ 0.05); violet dots, 
miRNAs whose expression correlates significantly in both mouse strains (FDR ≤ 0.05) with ρ ≥ |0.5| in at least one mouse strain. The Pearson correlation coefficient 
of 0.62 indicates the correlation of those data between the two mouse strains. (B) The 10 miRNAs with the strongest positive correlation with HA mRNA in each 
mouse strain. (c) The 10 miRNAs with the strongest negative correlation with HA mRNA in each mouse strain. §Significantly correlating (ρ ≥ |0.5|, FDR ≤ 0.05)  
when combining miRNA and HA mRNA expression data of DBA/2J and C57BL/6J mice. These miRNAs, therefore, correlate most strongly in both mouse strains  
(***p value ≤ 0.001; **p value ≤ 0.01; *p value ≤ 0.05). All p values were FDR corrected.
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identification of mirna subpopulations 
Whose expression correlates with ha 
mrna expression
To assess the degree of synchronization between regulation of 
miRNA populations and viral replication, we then tested to what 
extent the expression changes of infection-regulated miRNAs 
correlated with IAV HA mRNA levels. Expression of 105 miR-
NAs correlated significantly (ρ ≥ |0.5|, p ≤ 0.05) with HA mRNA 
expression in at least one mouse strain (Figure 9), expression of 
65 (62%) of which correlated positively. The degree of correlation 
with HA mRNA expression was similar to some extent between 
the two mouse strains, showing a significant (p ≤  0.05) linear 
correlation between DBA/2J and C57BL/6J mice (Pearson cor-
relation = 0.62). Of note, there were no miRNAs that correlated 
significantly in opposite directions in the two strains. Expression 
of the eight IAV-regulated miRNAs (except miR-467e-5p) that 
distinguished between the two mouse strains even before infection 
(AUC > 0.99) also correlated significantly with HA mRNA levels. 
Expression of 75 miRNAs, including miRNAs of the miR-21, 
miR-223, miR-34, and miR-449 correlated with both HA mRNA 
expression and any of the hematological parameters. Of note, 
expression of 30 miRNAs correlated with HA mRNA expression 
in at least one mouse strain, but did not significantly correlate 
with peripheral blood cell indices. Out of these, miR-208b-3p, 
miR-467b-5p, miR-345-3p, and miR-744-3p were differentially 
expressed during infection in both mouse strains. The results sug-
gest that there was substantial, but not perfect, synchronization 
between miRNome and HA mRNA expression. Accordingly, data 
shown in Figures 1, 2 and 4 clearly show, for instance, that in the 
DBA/2J strain HA mRNA expression peaked at 48 hpi, but global 
miRNA reprogramming continued to evolve through 120  hpi. 
Taken together, these results suggest that pulmonary miRNA 
regulation is not driven by viral replication only, but also by 
aspects of the tissue response, including immune cell infiltration, 
that can be temporally dissociated from viral replication.
stepwise selection of Putative 
Functionally important mirnas
The Venn diagram (Figure 10) illustrates the stepwise selection of 
the presumably functionally most meaningful infection-regulated 
miRNAs. The input consisted of all 473 miRNAs that passed the 
initial pre-analytical filter (see Materials and Methods). Criteria 
FigUre 10 | Venn diagram illustrating sequential identification of subpopulations of mirnas associated with influenza a virus infection dependent 
and independent of host genetic background. The Venn diagram shows the number of miRNAs that are regulated after infection in DBA/2J or C57BL/6J mice, 
those that are differentially expressed between both mouse strains at any time point (DBA/2J vs C57BL/6J), and those that correlate significantly with viral 
hemagglutinin (HA) mRNA (HA correlation) expression (see Materials and Methods). The diagram is based on the data shown in Figures 4, 5 and 9. The numbers of 
miRNAs whose expression differs depending on the host strain include also those miRNAs whose expression does not change during infection. The center box on 
the right identifies the 20 miRNAs that satisfy all these conditions. The box at the bottom indicates miRNAs that fit all conditions, except that their expression did not 
differ between the two host strains. Expression of the miRNAs marked in red was particularly similar between the two host strains, having a FC ≤|1.5| and FDR 
adjusted p value ≥ 0.1 (see Materials and Methods). The top and bottom boxes on the right indicate miRNAs that are differentially expressed after infection in 
C57BL/6J mice only and whose expression correlates with HA mRNA expression.
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for selection were (1) differential expression at any time point after 
IAV infection (FC ≥|1.5|, FDR ≤0.05) in either mouse strain, (2) 
significant difference in expression between the two mouse strains 
(ratio ≥|2|, FDR ≤0.01) at any time point, and (3) significant 
correlation with HA mRNA expression (ρ ≥|0.5|, FDR ≤0.05). 
Ninety-three miRNAs were regulated in the DBA/2J strain, 95 in 
the C57BL/6J strain, and 63 were differentially expressed between 
the two strains at any point in the time course (label “DBA2/J 
vs C57BL/6J” in Figure  10). Thirty-nine miRNAs were com-
monly regulated after infection and correlated with HA mRNA 
expression, indicating that they represent the general miRNome 
response independent of the host genetic background (box below 
the diagram). Differential expression of 15 of these miRNAs (indi-
cated in red) compared to uninfected mice was particularly similar 
between the two strains (FDR >0.1 and FC ≤|1.5|). Expression 
of 20 miRNAs that were regulated after infection in both strains 
and correlated with HA mRNA expression in addition differed 
significantly between the two mouse strains (Figure  10, center 
intersect and right box). These 20 miRNAs (which included 
miR34 families, which are strongly associated with regulation of 
apoptosis and the PI3k-Akt pathway [e.g., Figure 6]) thus consti-
tuted part of a highly regulated response that can predominate in 
either strain, depending on the time after infection, and is likely 
to play a role in host susceptibility. Expression of six miRNAs 
(identified in the top and bottom boxes, right side of the figure) 
was specifically regulated in the C57BL/6J strain and correlated 
with HA mRNA expression. This suggests that they constitute 
part of the host response specific to this strain that is most closely 
associated with IAV replication and may contribute to the relative 
resistance of this strain to IAV infection.
DiscUssiOn
We have performed a comprehensive comparison of global 
pulmonary miRNA reprogramming during IAV infection in two 
inbred mouse strains with genetically determined differential 
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susceptibility to this virus. This analysis revealed common and 
distinct features in the global miRNA expression pattern, and 
specific differences even in uninfected lungs, suggesting that host 
strain resistance/susceptibility may be programmed, at least in 
part, by the abundance of several miRNAs in the uninfected state.
Kinetics of mirnome reprogramming  
and role of infiltrating immune cells
In both mouse strains, substantial miRNome reprogramming 
became evident only by 48 hpi, i.e., well after completion of the 
first viral replication cycle. In contrast, in a related study using the 
same mouse strains, we detected infection-driven mRNA expres-
sion changes as early as 12 hpi (21). This suggests that miRNome 
reprogramming occurs with considerable delay compared to 
mRNA reprogramming and may thus be a reaction to, and not 
a cause of, mRNA-mediated changes in protein expression. The 
trajectory analysis suggested that infiltrating cells contribute sig-
nificantly to pulmonary miRNome reprogramming. In addition, 
pulmonary abundance of miRNAs with positive correlations with 
peripheral blood granulocytes and monocyte numbers initially 
tended to be low. These correlations were most pronounced in 
the more susceptible DBA/2J strain, and immune cell infiltra-
tion of neutrophils and macrophages into the lung on day 2 pi 
is indeed more extensive in this strain than in C57BL/6J mice 
(40). These observations suggest a model in which a substantial 
change in pulmonary miRNA populations is due to immigration 
of leukocytes into the lung, which likely contribute further to 
changes in pulmonary miRNomes due to their highly activated 
phenotype in this intensely infected tissue. Indeed, consistent 
with reports in IAV in other species (54, 55), several of the dif-
ferentially expressed miRNAs detected in our study are expressed 
in immune cells, including in peripheral blood. Of these, miR-
223-3p (whose expression correlated the most strongly with 
granulocyte numbers) is known to play important roles in the 
differentiation of myeloid cells, including neutrophils (56). By 
the same token, miRNAs highly abundant in uninfected lungs 
would stem from resident lung cells, and their abundance would 
appear to be lower due to “dilution” by the miRNAs expressed by 
immigrating cells. Obviously, this is a simplified model, as some 
of the upregulation of the miRNAs with initially low expression 
can also be due to the response of resident cells, for instance due 
to the activation of pathways relating to tissue injury or intrinsic 
immunity. Of note, the major features of miRNA reprogramming 
observed here agree well with our previous analysis of changes 
in hematological parameters during IAV infection, using the 
same mice (25). Similar to miRNA expression, peripheral blood 
indices (particularly granulocyte numbers) differed between the 
two strains already before infection, and changes became fully 
manifest from 48 hpi onward. Thus, pre-programmed differences 
in leukocyte number and responsiveness likely contribute to the 
observed differences in pulmonary miRNA populations.
The general Pulmonary mirna  
response to iaV infection
The Venn diagram (Figure  10) identifies 39 miRNAs whose 
expression levels were similar in the two host strains, changed 
significantly during IAV infection in both strains, and correlated 
with HA mRNA in either strain. Expression of 15 of these was 
particularly similar in the two strains (Figure 10, marked in red). 
Thus, these miRNAs likely constitute a major part of the general 
miRNA response to IAV infection in mouse lung irrespective of 
host genetic background. Functionally, this group can be linked 
to general responses expected in an infected organ. For instance, 
miR-142-5p plays critical roles in lymphocyte development and 
homeostasis (57), and miR-106a-5p, miR-130-3p, miR-20b-5p, 
miR-345-3p, and the miR-15 cluster have been associated with 
immune or stress responses (58–62). Of note, one of these miR-
NAs (miR-18a-5p) (as well as miR-223-3p, whose expression in 
addition differed between the two mouse strains) is among three 
miRNAs that were recently identified as being commonly regu-
lated in the response to IAV infection in all four species screened, 
i.e., humans, pig, chicken, and mouse (63). This suggests that part 
of this general pulmonary response is conserved across evolu-
tionarily diverse hosts of IAV.
Potential roles of mirnas in host-strain-
specific susceptibility and resistance to 
iaV infection
How might differential expression and regulation of miRNAs 
affect susceptibility in the two strains used? It is not easy to 
answer this question, as any miRNA may have several mRNAs 
targets, more than one miRNA can regulate the same mRNA, 
and both up- and downregulation of miRNAs may significantly 
affect levels of a given protein. In addition, the DBA/2J strain is 
considered a more “inflammogenic” host (20, 40) and it is, there-
fore, possible that a good portion of the miRNome response in 
this strain relates to the inflammatory response and not antiviral 
immunity per se.
The expression of 20 miRNAs with differential expression 
between the two host strains correlated significantly with HA 
mRNA expression, suggesting that they closely relate to host 
susceptibility or resistance (Figure  10, center). The expression 
of miRNAs that play a role in host-strain susceptibility or resist-
ance is expected to correlate with the virulence of the pathogen. 
Indeed, changes in expression of several of these 20 miRNAs 
(miR-147-3p, miR-155-3p, miR-223-3p, as well as the miR-34 
and miR-449 families) correlate with IAV virulence (14, 15, 17, 
64). In addition, several of them have been implicated function-
ally in the host response to IAV (14, 16–18, 64) or other viruses, 
suggesting that their differential expression in our model is 
functionally relevant. For instance, miR-449-5p exerts anti-IAV 
activities by inhibiting histone deacetylase and, therefore, induc-
ing IFNβ expression (18), and inhibition of miR-223-3p (which 
was more highly expressed in the DBA/2J strain in our study) 
reduced mortality and delayed death of H5N2-infected mice (64). 
The miR-34 and miR-449 families control epithelial barrier repair 
(65) and regulate multiciliogenesis via the Delta/Notch pathway 
(66, 67), which might help transport virions out of the respira-
tory tract (68) and reduce end-organ damage. Of these two, the 
miR-449 family is of considerable interest with respect to the 
higher resistance of C57BL/6J mice, because—in addition to their 
different abundance in the two strains—these miRNAs were more 
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strongly induced in C57BL/6J mice, suggesting that their higher 
abundance is less due to mere leukocyte infiltration. Differential 
expression of several of these 20 miRNAs may affect the outcome 
of IAV infection by regulating overall inflammation. miR-147-3p 
has been reported to negatively regulate TLR signaling in murine 
macrophages (69). miR-223-3p dampens NLRP3 inflammasome 
activity (70) and can inhibit inflammation by targeting STAT3 
(71). However, it was more highly upregulated in the DBA/2J 
strain, suggesting that its anti-inflammatory effects did not 
dominate. Two of the 20 miRNAs (miR-31-5p and miR-182-5p) 
can be linked to adaptive immunity, i.e., T  cell activation and 
regulation of Treg differentiation, respectively (72, 73). However, 
taken together the results suggest that immune functions of this 
central group of miRNAs predominantly affect host susceptibility 
to IAV infection by modulating innate immune responses and 
inflammation.
Potential roles of mirna regulation of 
apoptosis and the Pi3K Pathway in host 
susceptibility
The higher abundance of potentially antiapoptotic miRNAs 
in the DBA/2J strain suggests a plausible role in the higher 
susceptibility of this strain. The IAV NS1 protein can activate 
the PI3K pathway, which leads to antiapoptotic responses and, 
subsequently, higher virulence (74). The higher abundance of 
antiapoptotic miRNAs even before infection in DBA/2J mice, 
therefore, supports the hypothesis that they contribute to host 
susceptibility by enhancing viral spread. In agreement with this 
model, several of the miRNAs with differential abundance in 
the two mouse strains have been shown to regulate the PI3K 
pathway, which relates strongly to apoptosis (see above) as well 
as phagocytosis (51, 75). In particular, a subgroup of seven 
downregulated and abundant miRNAs that were less abundant 
in DBA/2J mice were enriched for this pathway. The NS1 protein 
activates the PI3K pathway by binding the SH3 domain of PI3K, 
and overexpression of heterologous SH3 domain has been shown 
to inhibit viral replication (76). In our study, putative mRNA 
targets were enriched for SH3 domain binding proteins, and 
one may speculate that inhibiting expression of endogenous 
SH3-binding proteins might have a similar effect by making SH3 
domains more accessible to the NS protein. Indeed, induction of 
Cxcl10 requires the PI3K/Akt pathway (77), and Cxcl10 is much 
more strongly upregulated in DBA/2J than in C57BL/6J mice 
(20, 21).
highly Discriminatory (Predictive) mirnas
Of note, we identified a group of regulated miRNAs whose 
abundances differentiated between the two mouse strains before 
infection and in the earliest stages of infection (Figure  7) and 
might, therefore, be used to predict the outcome of the infection 
in the uninfected host. The miR-467 family was strongly repre-
sented in this group. In addition to its role in apoptosis, miR-
467b-5p targets the Lpl gene in macrophages and thereby limits 
lipid accumulation and pro-inflammatory cytokine secretion 
(78). Also, miR-147-3p can dampen TLR-signaling in murine 
macrophages (69). Thus, their likely function in the host response 
to IAV is to limit excessive inflammation. For the other miRNAs 
in this group, reports of functions relating to infection could not 
be found. However, they might play yet unknown roles and might 
be interesting candidates for future investigations regarding host-
strain susceptibility to IAV infection. Interestingly, miR-3096a-5p 
and miR-3096b-3p, which by far showed the strongest host-strain 
differences, may constitute non-canonical (DICER independent) 
miRNAs (www.mirBase.org).
mirnas with Potential Binding sites in  
the iaV genome
The identification of miRNAs whose human homologs have 
potential binding sites in the IAV genome is of considerable inter-
est. These miRNAs were more highly expressed in C57BL/6J than 
DBA/2J mice and might, therefore, contribute to the higher resist-
ance of the C57BL/6J strain. Of note, miR-31-5p, miR-379-5p, 
miR-7a-5p, as well as some members of the miR-449 (-5p) and 
miR-34 (-5p) families were moderately to highly abundant (>10 
CPM), making it more likely that they would bind to a biologi-
cally relevant number of viral RNAs.
mirnas and Their counterparts
For some host strain-dependently regulated miRNAs, such as 
miR-21a-3p and miR-155-3p, we found a high number of validated 
functions for their counterparts miR-21a-5p and miR-155-5p. We 
propose that the ratio between these forms might also be relevant 
to their function. For example, a study found opposite roles of 
miR-155-3p and miR-155-5p, in that they activated and inhibited 
TLR7-mediated type I interferon production, respectively. In this 
model, predominance of miR-155-3p would favor activation of 
this process.
conclusion
Using two mouse strains of greatly differing genetic susceptibil-
ity to IAV infection, we found substantial differences in pulmo-
nary miRNA expression even before infection, which evolved 
further throughout infection and could in part be attributed 
to differences in leukocyte populations before and during 
infection. Before infection, host susceptibility was particularly 
associated with consistently higher expression of miR-208b-3p, 
miR-3096b-3p, and the miR-467 family and lower expression 
of miR-3096a-5p and the potentially anti-inflammatory miR-
147-3p. During infection, susceptibility correlated with a shift 
toward higher expression of miRNAs inhibiting apoptosis but 
lower expression of miRNAs associated with regulation of 
PI3K-Akt signaling, i.e., two processes known to play important 
roles in the host response to IAV infection. These results suggest 
that pulmonary miRNA populations before and during IAV 
infection are in part determined genetically and contribute to 
susceptibility to IAV infection in this murine host, and likely 
in humans.
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